1
|
Jemal A, Siegel R, Ward E, Murray T, Xu J,
Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin.
56:106–130. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Saba NF and Khuri FR: Chemoprevention
strategies for patients with lung cancer in the context of
screening. Clin Lung Cancer. 7:92–99. 2005. View Article : Google Scholar : PubMed/NCBI
|
3
|
Chou JY, Lai SY, Pan SL, Jow GM, Chern JW
and Guh JH: Investigation of anticancer mechanism of
thiadiazole-based compound in human non-small cell lung cancer A549
cells. Biochem Pharmacol. 66:115–124. 2003. View Article : Google Scholar : PubMed/NCBI
|
4
|
Bonomi P, Kim K, Fairclough D, Cella D,
Kugler J, Rowinsky E, Jiroutek M and Johnson D: Comparison of
survival and quality of life in advanced non-small-cell lung cancer
patients treated with two dose levels of paclitaxel combined with
cisplatin versus etoposide with cisplatin: Results of an Eastern
Cooperative Oncology Group trial. J Clin Oncol. 18:623–631.
2000.PubMed/NCBI
|
5
|
Lin Y, Xu J, Liao H, Li L and Pan L:
Piperine induces apoptosis of lung cancer A549 cells via
p53-dependent mitochondrial signaling pathway. Tumour Biol.
35:3305–3310. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Rasul A, Bao R, Malhi M, Zhao B, Tsuji I,
Li J and Li X: Induction of apoptosis by costunolide in bladder
cancer cells is mediated through ROS generation and mitochondrial
dysfunction. Molecules. 18:1418–1433. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Bonomi P: Review of paclitaxel/carboplatin
in advanced non-small cell lung cancer. Semin Oncol. 26(Suppl 2):
S55–S59. 1999.
|
8
|
Gu JQ, Gills JJ, Park EJ, Mata-Greenwood
E, Hawthorne ME, Axelrod F, Chavez PI, Fong HH, Mehta RG, Pezzuto
JM and Kinghorn AD: Sesquiterpenoids from Tithonia diversifolia
with potential cancer chemopreventive activity. J Natl Prod.
65:532–536. 2002. View Article : Google Scholar
|
9
|
Koch E, Klaas CA, Rüngeler P, Castro V,
Mora G, Vichnewski W and Merfort I: Inhibition of inflammatory
cytokine production and lymphocyte proliferation by structurally
different sesquiterpene lactones correlates with their effect on
activation of NF-kappaB. Biochem Pharmacol. 62:795–801. 2001.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Robles M, Aregullin M, West J and
Rodriguez E: Recent studies on the zoopharmacognosy, pharmacology
and neurotoxicology of sesquiterpene lactones. Planta Med.
61:199–203. 1995. View Article : Google Scholar : PubMed/NCBI
|
11
|
Park HJ, Jung WT, Basnet P, Kadota S and
Namba T: Syringin 4-O-beta-glucoside, a new phenylpropanoid
glycoside and costunolide, a nitric oxide synthase inhibitor, from
the stem bark of Magnolia sieboldii. J Nat Prod. 59:1128–1130.
1996. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wedge DE, Galindo JC and Macías FA:
Fungicidal activity of natural and synthetic sesquiterpene lactone
analogs. Phytochemistry. 53:747–757. 2000. View Article : Google Scholar : PubMed/NCBI
|
13
|
Chen HC, Chou CK, Lee SD, Wang JC and Yeh
SF: Active compounds from Saussurea lappa Clarks that suppress
hepatitis B virus surface antigen gene expression in human hepatoma
cells. Antiviral Res. 27:99–109. 1995. View Article : Google Scholar : PubMed/NCBI
|
14
|
Koo TH, Lee JH, Park YJ, Hong YS, Kim HS,
Kim KW and Lee JJ: A sesquiterpene lactone, costunolide, from
Magnolia grandiflora inhibits NF-kappa B by targeting I kappa B
phosphorylation. Planta Med. 67:103–107. 2001. View Article : Google Scholar : PubMed/NCBI
|
15
|
Fukuda K, Akao S, Ohno Y, Yamashita K and
Fujiwara H: Inhibition by costunolide of phorbol ester-induced
transcriptional activation of inducible nitric oxide synthase gene
in a human monocyte cell line THP-1. Cancer Lett. 164:7–13. 2001.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Choi JH, Ha J, Park JH, Lee JY, Lee YS,
Park HJ, Choi JW, Masuda Y, Nakaya K and Lee KT: Costunolide
triggers apoptosis in human leukemia U937 cells by depleting
intracellular thiols. Jpn J Cancer Res. 93:1327–1333. 2002.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Kim SH, Kang SN, Kim HJ and Kim TS:
Potentiation of 1,25-dihydroxyvitamin D(3)-induced differentiation
of human promyelocytic leukemia cells into monocytes by
costunolide, a germacranolide sesquiterpene lactone. Biochem
Pharmacol. 64:1233–1242. 2002. View Article : Google Scholar : PubMed/NCBI
|
18
|
Choi YK, Cho SG, Woo SM, Yun YJ, et al:
Saussurea lappa clarke-derived costunolide prevents TNF α-induced
breast cancer cell migration and invasion by inhibiting NF-κB
activity. Evid Based Complement Alternat Med. 2013:9362572013.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Choi YK, Seo HS, Choi HS, Choi HS, Kim SR,
Shin YC and Ko SG: Induction of Fas-mediated extrinsic apoptosis,
p21WAF1-related G2/M cell cycle arrest and ROS generation by
costunolide in estrogen receptor-negative breast cancer cells,
MDA-MB-231. Mol Cell Biochem. 363:119–128. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Liu CY, Chang HS, Chen IS, Chen CJ, Hsu
ML, Fu SL and Chen YJ: Costunolide causes mitotic arrest and
enhances radiosensitivity in human hepatocellular carcinoma cells.
Radiat Oncol. 6:562011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Hsu JL, Pan SL, Ho YF, Hwang TL, Kung FL
and Guh JH: Costunolide induces apoptosis through nuclear calcium2+
overload and DNA damage response in human prostate cancer. J Urol.
185:1967–1974. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Choi JH and Lee KT: Costunolide-induced
apoptosis in human leukemia cells: Involvement of c-jun N-terminal
kinase activation. Biol Pharm Bull. 32:1803–1808. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Choi SH, Im E, Kang HK, Lee JH, Kwak HS,
Bae YT, Park HJ and Kim ND: Inhibitory effects of costunolide on
the telomerase activity in human breast carcinoma cells. Cancer
Lett. 227:153–162. 2005. View Article : Google Scholar : PubMed/NCBI
|
24
|
Komiya T, Yamada Y, Moteki H, Katsuzaki H,
Imai K and Hibasami H: Hot water soluble sesquiterpenes
[anhydroperoxy-costunolide and 3-oxoeudesma-1,4 (15),11
(13)triene-12,6alpha-olide] isolated from laurel (Laurus
nobilis L.) induce cell death and morphological change
indicative of apoptotic chromatin condensation in leukemia cells.
Oncol Rep. 11:85–88. 2004.PubMed/NCBI
|
25
|
Hibasami H, Yamada Y, Moteki H, Katsuzaki
H, Imai K, Yoshioka K and Komiya T: Sesquiterpenes (costunolide and
zaluzanin D) isolated from laurel (Laurus nobilis L.) induce cell
death and morphological change indicative of apoptotic chromatin
condensation in leukemia HL-60 cells. Int J Mol Med. 12:147–151.
2003.PubMed/NCBI
|
26
|
Kretschmer N, Rinner B, Stuendl N,
Kaltenegger H, Wolf E, Kunert O, Boechzelt H, Leithner A, Bauer R
and Lohberger B: Effect of costunolide and dehydrocostus lactone on
cell cycle, apoptosis and ABC transporter expression in human soft
tissue sarcoma cells. Planta Med. 78:1749–1756. 2012. View Article : Google Scholar : PubMed/NCBI
|
27
|
Yang YI, Kim JH and Choi JH: Costunolide
induces apoptosis in platinum-resistant human ovarian cancer cells
by generating reactive oxygen species. Gynecol Oncol. 123:588–596.
2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
King KL and Cidlowski JA: Cell cycle
regulation and apoptosis. Ann Rev Physiol. 60:601–617. 1998.
View Article : Google Scholar
|
29
|
Collins K, Jacks T and Pavletich NP: The
cell cycle and cancer. Proc Natl Acad Sci USA. 94:2776–2778. 1997.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Pan J, She M, Xu ZX, Sun L and Yeung SC:
Farnesyltransferase inhibitors induce DNA damage via reactive
oxygen species in human cancer cells. Cancer Res. 65:3671–3681.
2005. View Article : Google Scholar : PubMed/NCBI
|
31
|
Bergamo A, Gagliardi R, Scarcia V, Furlani
A, Alessio E, Mestroni G and Sava G: In vitro cell cycle arrest, in
vivo action on solid metastasizing tumors and host toxicity of the
antimetastatic drug NAMI-A and cisplatin. J Pharmacol Exp Ther.
289:559–564. 1999.PubMed/NCBI
|
32
|
Horwitz SB: Taxol (paclitaxel): Mechanisms
of action. Ann Oncol. 5(Suppl 6): S3S61994.
|
33
|
Fridman JS and Lowe SW: Control of
apoptosis by p53. Oncogene. 22:9030–9040. 2003. View Article : Google Scholar : PubMed/NCBI
|
34
|
Budram-Mahadeo V, Morris PJ and Latchman
DS: The Brn-3a transcription factor inhibits the pro-apoptotic
effect of p53 and enhances cell cycle arrest by differentially
regulating the activity of the p53 target genes encoding Bax and
p21(CIP1/Waf1). Oncogene. 21:6123–6131. 2002. View Article : Google Scholar : PubMed/NCBI
|
35
|
Tchernev G and Orfanos CE: Downregulation
of cell cycle modulators p21, p27, p53, Rb and proapoptotic
Bcl-2-related proteins Bax and Bak in cutaneous melanoma is
associated with worse patient prognosis: Preliminary findings. J
Cutan Pathol. 34:247–256. 2007. View Article : Google Scholar : PubMed/NCBI
|
36
|
Polyak K, Kato JY, Solomon MJ, Sherr CJ,
Massague J, Roberts JM and Koff A: p27Kip1, a cyclin-Cdk inhibitor,
links transforming growth factor-beta and contact inhibition to
cell cycle arrest. Genes Dev. 8:9–22. 1994. View Article : Google Scholar : PubMed/NCBI
|
37
|
Rasul A, Ding C, Li X, Khan M, Yi F, Ali M
and Ma T: Dracorhodin perchlorate inhibits PI3K/Akt and NF-κB
activation, up-regulates the expression of p53 and enhances
apoptosis. Apoptosis. 17:1104–1119. 2012. View Article : Google Scholar : PubMed/NCBI
|
38
|
Sakuragi N, Salah-eldin AE, Watari H, Itoh
T, Inoue S, Moriuchi T and Fujimoto S: Bax, Bcl-2 and p53
expression in endometrial cancer. Gynecol Oncol. 86:288–296. 2002.
View Article : Google Scholar : PubMed/NCBI
|
39
|
Frenzel A, Grespi F, Chmelewskij W and
Villunger A: Bcl2 family proteins in carcinogenesis and the
treatment of cancer. Apoptosis. 14:584–596. 2009. View Article : Google Scholar : PubMed/NCBI
|
40
|
Ly JD, Grubb DR and Lawen A: The
mitochondrial membrane potential (deltapsi(m)) in apoptosis; an
update. Apoptosis. 8:115–128. 2003. View Article : Google Scholar : PubMed/NCBI
|
41
|
Porter AG and Jünicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|